Literature DB >> 19942427

HIF-1: upstream and downstream of cancer metabolism.

Gregg L Semenza1.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) plays a key role in the reprogramming of cancer metabolism by activating transcription of genes encoding glucose transporters and glycolytic enzymes, which take up glucose and convert it to lactate; pyruvate dehydrogenase kinase 1, which shunts pyruvate away from the mitochondria; and BNIP3, which triggers selective mitochondrial autophagy. The shift from oxidative to glycolytic metabolism allows maintenance of redox homeostasis and cell survival under conditions of prolonged hypoxia. Many metabolic abnormalities in cancer cells increase HIF-1 activity. As a result, a feed-forward mechanism can be activated that drives HIF-1 activation and may promote tumor progression. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19942427      PMCID: PMC2822127          DOI: 10.1016/j.gde.2009.10.009

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  47 in total

1.  Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.

Authors:  Elhadji M Dioum; Rui Chen; Matthew S Alexander; Quiyang Zhang; Richard T Hogg; Robert D Gerard; Joseph A Garcia
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

2.  Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains.

Authors:  Grégory Bellot; Raquel Garcia-Medina; Pierre Gounon; Johanna Chiche; Danièle Roux; Jacques Pouysségur; Nathalie M Mazure
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

3.  Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.

Authors:  Thomas McFate; Ahmed Mohyeldin; Huasheng Lu; Jay Thakar; Jeremy Henriques; Nader D Halim; Hong Wu; Michael J Schell; Tsz Mon Tsang; Orla Teahan; Shaoyu Zhou; Joseph A Califano; Nam Ho Jeoung; Robert A Harris; Ajay Verma
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

4.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

Authors:  Pierre Sonveaux; Frédérique Végran; Thies Schroeder; Melanie C Wergin; Julien Verrax; Zahid N Rabbani; Christophe J De Saedeleer; Kelly M Kennedy; Caroline Diepart; Bénédicte F Jordan; Michael J Kelley; Bernard Gallez; Miriam L Wahl; Olivier Feron; Mark W Dewhirst
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

5.  SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.

Authors:  G Boily; X H He; B Pearce; K Jardine; M W McBurney
Journal:  Oncogene       Date:  2009-06-08       Impact factor: 9.867

6.  mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.

Authors:  David B Shackelford; Debbie S Vasquez; Jacqueline Corbeil; Shulin Wu; Mathias Leblanc; Chin-Lee Wu; David R Vera; Reuben J Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

7.  Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L.

Authors:  I Papandreou; A L Lim; K Laderoute; N C Denko
Journal:  Cell Death Differ       Date:  2008-06-13       Impact factor: 15.828

Review 8.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

9.  Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts.

Authors:  David R Mole; Christine Blancher; Richard R Copley; Patrick J Pollard; Jonathan M Gleadle; Jiannis Ragoussis; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

Review 10.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more
  514 in total

Review 1.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

2.  CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.

Authors:  Renaud Le Floch; Johanna Chiche; Ibtissam Marchiq; Tanesha Naiken; Tanesha Naïken; Karine Ilc; Karine Ilk; Clare M Murray; Susan E Critchlow; Danièle Roux; Marie-Pierre Simon; Jacques Pouysségur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

3.  Distinct energy metabolism of auditory and vestibular sensory epithelia revealed by quantitative mass spectrometry using MS2 intensity.

Authors:  Kateri J Spinelli; John E Klimek; Phillip A Wilmarth; Jung-Bum Shin; Dongseok Choi; Larry L David; Peter G Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  mTOR links incretin signaling to HIF induction in pancreatic beta cells.

Authors:  Sam Van de Velde; Meghan F Hogan; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis.

Authors:  Facundo G Pelorosso; Allan Balmain
Journal:  EMBO J       Date:  2010-12-15       Impact factor: 11.598

6.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

Review 7.  Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.

Authors:  Bojana Ristic; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-05-13       Impact factor: 10.680

8.  IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism.

Authors:  Atsuhito Tsuji; Takumi Akao; Takahiro Masuya; Masatoshi Murai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

9.  DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia.

Authors:  Gabriel Lachance; James Uniacke; Timothy E Audas; Chet E Holterman; Aleksandra Franovic; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-09       Impact factor: 11.205

10.  Metabolic signature identifies novel targets for drug resistance in multiple myeloma.

Authors:  Patricia Maiso; Daisy Huynh; Michele Moschetta; Antonio Sacco; Yosra Aljawai; Yuji Mishima; John M Asara; Aldo M Roccaro; Alec C Kimmelman; Irene M Ghobrial
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.